Bavarian Nordic A/S (OTCMKTS:BVNRY) Posts Earnings Results

Bavarian Nordic A/S (OTCMKTS:BVNRY) issued its quarterly earnings data on Friday. The company reported $0.13 EPS for the quarter, Zacks reports. Bavarian Nordic A/S had a net margin of 18.33% and a return on equity of 10.65%. The business had revenue of $189.89 million during the quarter.

Bavarian Nordic A/S Price Performance

Shares of Bavarian Nordic A/S stock opened at $8.25 on Friday. The company has a 50-day moving average of $7.65 and a 200 day moving average of $8.53. Bavarian Nordic A/S has a 1 year low of $6.60 and a 1 year high of $14.60. The firm has a market cap of $1.95 billion, a price-to-earnings ratio of 11.96 and a beta of 1.44.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.